Climb Global Solutions (CLMB) Q2 2026 Earnings Call Transcript

Climb Global Solutions reported Q2 2026 gross billings of $587.3M (+17% YoY) and net sales of $174.2M (+9% YoY), with gross profit up 15% to $30.2M, supported by double-digit organic growth and the Interworks acquisition. However, GAAP net income fell to $5.5M ($0.30/share) from $6.0M ($0.33) due to a higher effective tax rate, while adjusted EBITDA was roughly flat at $11.3M and effective margin declined 580 bps to 37.5% on increased investments (noted ~$0.5M nonrecurring legal/professional + IT). Management reiterated a longer-term goal to more than double FY2025 adjusted EBITDA by 2030 and said it is evaluating two large acquisition targets, potentially using debt despite remaining debt-free with $56.6M cash and no borrowings on the $50M revolver.

Analysis

CLMB’s setup is less about the reported quarter than about whether it can turn a few high-value vendor relationships into repeatable share gains. In channel distribution, the economics are driven by mix and frequency, so the real upside comes if FTNT and ADBE deepen wallet share faster than the company’s cost base rises; that would make the current SG&A step-up look like an early-stage platform build rather than margin leakage.

Near term, the market is likely to fixate on flat EBITDA and margin pressure, but that misses the second-order signal: management is deliberately buying future operating leverage with systems spend and field coverage. If the larger-vendor ramps stick, CLMB can outgrow its fixed-cost base into 2027; if they do not, the company is simply adding complexity and headline growth without durable profit conversion.

The bigger strategic wildcard is Europe and M&A. A debt-funded acquisition could improve the mix if it brings structurally higher gross margins and less competitive intensity, but it also raises integration and balance-sheet risk for a business that currently screens as conservative. Falsifiers are simple: if gross-billings growth drops back to low-double-digits, FTNT loses momentum after the initial channel expansion, or SG&A remains stuck above the low-3% range without EBITDA leverage, the rerating case should be deferred.

Key Decisions for Investors

• Buy CLMB on post-earnings weakness only, targeting a 3-6 month trade; add if the stock sells off >7% on margin fears, with a stop if Q3 gross billings growth falls below ~12% or SG&A fails to leverage.
• Stay long FTNT as the cleaner beneficiary of channel expansion; use a 1-3 month call-spread structure rather than common stock to capture upside from distributor share gains without paying full multiple for execution risk.
• Do not chase ADBE yet; treat the marketplace integration as a Q4/Q1 watch item and only add if renewal/attach metrics show the platform is reducing friction rather than just creating a new sales layer.
• Avoid shorting CLMB outright; if you want expression on the thesis, pair a small long CLMB with a hedge in a broader software/distribution proxy until the next quarter proves the vendor ramps are durable.